CPT code 71260 covers computed tomography of the chest with intravenous contrast. This study is commonly ordered for evaluation of chest masses, pulmonary embolism (PE), mediastinal pathology, and cancer staging.
CT chest with contrast generally requires prior authorization from major insurers. However, CT pulmonary angiography for suspected PE is often expedited or exempt from standard PA review due to clinic... Always verify requirements with the specific insurer and plan.
CT chest with contrast is used to evaluate suspected pulmonary embolism, lung nodules and masses, mediastinal lymphadenopathy, aortic pathology, cancer staging, and complex pleural disease. CT pulmonary angiography (CTA) for PE evaluation is a common use of this study.
CT chest with contrast generally requires prior authorization from major insurers. However, CT pulmonary angiography for suspected PE is often expedited or exempt from standard PA review due to clinical urgency. Cancer staging CT is also generally approved when properly documented.
Note: PA requirements vary by specific plan and member. Always verify requirements with the insurer before scheduling.
For suspected PE, document the clinical probability score (Wells criteria) and D-dimer results.
Include chest X-ray findings and explain why CT is needed for further evaluation.
For cancer staging, document the known diagnosis and specific staging questions.
Clearly distinguish between CT chest with contrast and low-dose CT lung screening (LDCT), which has a separate pathway.
Document clinical urgency for time-sensitive conditions.
Greenlight Medical detects when CPT 71260 requires prior auth, assembles all documentation automatically, and submits to the correct payer portal. No manual lookups, no phone calls, no faxes.
See Greenlight in ActionYes, CT chest with contrast (CPT 71260) generally requires prior authorization. However, urgent indications like suspected pulmonary embolism are often expedited or have modified PA pathways. Always check the specific insurer's requirements.
Yes. CT chest with contrast (CPT 71260) is a diagnostic study requiring PA. Low-dose CT lung screening (CPT 71271) is a preventive screening with separate coverage criteria based on smoking history and age. They follow different PA pathways.
CTA for PE evaluation uses CPT 71275. While technically subject to PA, most insurers have expedited or modified review pathways for suspected PE given the clinical urgency. Document the clinical presentation and Wells criteria score to support the request.